Showing results (111-120 of 258) with videos related to
Sort By:
Pageof 26
Cancers|September 9, 2023
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA RepairMonica Ganzinelli, Federica Guffanti, Anna Ianza, et al.Breast Cancer Research and Treatment|August 22, 2013
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signalingClaudia Fumarola, Cristina Caffarra, Silvia La Monica, et al.Journal of the National Cancer Institute. Monographs|November 2, 2011
Molecular oncology and the neoadjuvant setting: the perfect blend for treatment personalization and clinical trial designDaniele Generali, Alfredo Berruti, Chiara Foroni, et al.Oncotarget|November 24, 2015
Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognitionMartina Di Modica, Lucia Sfondrini, Viola Regondi, et al.Breast (Edinburgh, Scotland)|August 13, 2023
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in ItalyAlberto Zambelli, Marina Cazzaniga, Nicla La Verde, et al.NPJ Breast Cancer|January 28, 2026
Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncologyGiuseppe Di Grazia, Rodrigo Sánchez-Bayona, Climent Casals-Pascual, et al.Expert Opinion on Investigational Drugs|May 3, 2018
Lenvatinib for the treatment of renal cell carcinomaGiandomenico Roviello, Silvia Paola Corona, Giovanni Bozza, et al.Cancer Treatment Reviews|August 25, 2024
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implicationsFrancesco Schettini, Federica Gattazzo, Sabrina Nucera, et al.Plos One|July 24, 2026
Decision tree model to assess consequences and costs associated with therapy administration pathways for patients with HER2+ breast cancer in Italian oncological centersGiorgia Gribaudo, Carla Fornari, Ippazio Cosimo Antonazzo, et al.Critical Reviews in Oncology/Hematology|November 12, 2019
Granular cell tumor of the breast: a multidisciplinary challengeFrancesco Meani, Simona Di Lascio, Wiebke Wandschneider, et al.Pageof 26